J.L. Werth

1.0k total citations
13 papers, 887 citations indexed

About

J.L. Werth is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, J.L. Werth has authored 13 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in J.L. Werth's work include Neuroscience and Neuropharmacology Research (3 papers), Asthma and respiratory diseases (3 papers) and Pharmaceutical studies and practices (3 papers). J.L. Werth is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Asthma and respiratory diseases (3 papers) and Pharmaceutical studies and practices (3 papers). J.L. Werth collaborates with scholars based in United States, Belgium and Canada. J.L. Werth's co-authors include Herbert Weissbach, N Brot, Lawrence Weissbach, Yuriy M. Usachev, Stanley A. Thayer, Louise M. Nutter, Douglas E. Feltner, Danièle Ouellet, Lane D. Hirning and Gregor Novak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Journal of Investigative Dermatology.

In The Last Decade

J.L. Werth

13 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.L. Werth United States 8 675 360 167 82 70 13 887
Alexander Surin Russia 16 811 1.2× 496 1.4× 156 0.9× 51 0.6× 32 0.5× 49 1.2k
Maria L. Maccecchini United States 12 641 0.9× 192 0.5× 154 0.9× 97 1.2× 62 0.9× 21 882
Péter Csutora United States 15 786 1.2× 292 0.8× 140 0.8× 93 1.1× 97 1.4× 20 1.2k
Agnès Müller France 14 371 0.5× 186 0.5× 187 1.1× 43 0.5× 69 1.0× 23 735
Amal Kanti Bera India 22 1.1k 1.6× 320 0.9× 147 0.9× 59 0.7× 27 0.4× 59 1.5k
Che‐Chang Hsu United States 14 460 0.7× 310 0.9× 90 0.5× 113 1.4× 85 1.2× 18 877
Takahiko Kato Japan 15 517 0.8× 164 0.5× 138 0.8× 72 0.9× 88 1.3× 43 935
María F. Cano‐Abad Spain 17 731 1.1× 337 0.9× 154 0.9× 89 1.1× 35 0.5× 40 1.2k
Hatsue Waki Japan 16 595 0.9× 212 0.6× 209 1.3× 129 1.6× 22 0.3× 30 859
Rosalba I. Fonteríz Spain 20 1.0k 1.5× 448 1.2× 185 1.1× 172 2.1× 50 0.7× 43 1.4k

Countries citing papers authored by J.L. Werth

Since Specialization
Citations

This map shows the geographic impact of J.L. Werth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Werth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Werth more than expected).

Fields of papers citing papers by J.L. Werth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Werth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Werth. The network helps show where J.L. Werth may publish in the future.

Co-authorship network of co-authors of J.L. Werth

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Werth. A scholar is included among the top collaborators of J.L. Werth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Werth. J.L. Werth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Spergel, Jonathan M., Michael S. Blaiss, Peter Lio, et al.. (2020). P500 EFFICACY OF CRISABOROLE IN PATIENTS WITH MILD-TO-MODERATE ATOPIC DERMATITIS WITH AND WITHOUT COMORBID ALLERGIC RHINITIS. Annals of Allergy Asthma & Immunology. 125(5). S46–S46. 1 indexed citations
2.
Purohit, Vivek S., J.L. Werth, D. Graham, & Timothy Nicholas. (2020). 512 Patient and disease characteristic predictors of systemic exposure to crisaborole. Journal of Investigative Dermatology. 140(7). S70–S70. 1 indexed citations
3.
Guttman‐Yassky, Emma, Ana B. Pavel, Aisleen Diaz, et al.. (2019). 565 Improvement in skin inflammation and barrier function biomarkers with crisaborole treatment in atopic dermatitis (AD). Journal of Investigative Dermatology. 139(5). S97–S97. 1 indexed citations
4.
Ketter, Nzeera, Di Jiang, Lawrence S. Honig, et al.. (2016). A RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY OF THE EFFECTS OF THE VACCINE VANUTIDE CRIDIFICAR WITH QS-21 ADJUVANT ON IMMUNOGENICITY, SAFETY AND AMYLOID IMAGING IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 3(4). 1–10. 22 indexed citations
5.
Ouellet, Danièle, et al.. (2008). The Use of a Clinical Utility Index to Compare Insomnia Compounds: A Quantitative Basis for Benefit–Risk Assessment. Clinical Pharmacology & Therapeutics. 85(3). 277–282. 20 indexed citations
6.
Ouellet, Danièle, et al.. (2006). OII-A-2The use of a clinical utility index in decision making to select an insomnia compound. Clinical Pharmacology & Therapeutics. 79(2). P28–P28. 2 indexed citations
7.
Feltner, Douglas E., Mark H. Pollack, J. Davidson, et al.. (2000). A placebo-controlled, double-blind study of pregabalin treatment of social phobia: Outcome and predictors of response. European Neuropsychopharmacology. 10. 344–345. 9 indexed citations
8.
Pande, Arindam, Jerri G. Crockatt, Douglas E. Feltner, Maria Liu-Dumaw, & J.L. Werth. (2000). Three randomised, placebo-controlled, double-blind trials of pregabalin treatment of Generalized Anxiety Disorder (GAD). European Neuropsychopharmacology. 10. 344–344. 2 indexed citations
9.
Werth, J.L., et al.. (1996). Modulation of calcium efflux from cultured rat dorsal root ganglion neurons. Journal of Neuroscience. 16(3). 1008–1015. 82 indexed citations
10.
Werth, J.L., et al.. (1994). Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. Journal of Neuroscience. 14(1). 348–356. 421 indexed citations
11.
Werth, J.L., et al.. (1994). 2',3'-Dideoxycytidine alters calcium buffering in cultured dorsal root ganglion neurons.. Molecular Pharmacology. 45(6). 1119–1124. 19 indexed citations
12.
Werth, J.L., Lane D. Hirning, & Stanley A. Thayer. (1991). omega-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15.. PubMed. 40(5). 742–9. 10 indexed citations
13.
Brot, N, Lawrence Weissbach, J.L. Werth, & Herbert Weissbach. (1981). Enzymatic reduction of protein-bound methionine sulfoxide.. Proceedings of the National Academy of Sciences. 78(4). 2155–2158. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026